ClinicalTrials.gg
CompletedNCT00890071Updated Apr 29, 2009

Brachial Artery Peak Velocity Variation to Predict Fluid Responsiveness

An observational study in Hypotension and Shock, sponsored by Hospital del SAS de Jerez. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-04-29.

Sponsored by Hospital del SAS de Jerez · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
38
Ages
18 Years and older
Sex
All
01

Study summary

The investigators designed this study to determine the predictive value for predicting fluid responsiveness of noninvasive evaluation of respiratory variation of peak velocity in brachial artery, in mechanically ventilated patients with acute circulatory failure.

Read the detailed description

Predicting the hemodynamic response to fluid administration (or fluid responsiveness) in critical ill patients is still a matter of concern, since fluid overload could worse the clinical situation of these patients. Parameters of fluid responsiveness usually require an invasive monitoring (like arterial pulse pressure variation).

We hypothesize that noninvasive evaluation of respiratory variation of peak velocity in brachial artery using Doppler ultrasound could provide a feasible estimation on fluid responsiveness in mechanically ventilated patients with acute circulatory failure.

02

Conditions studied

  • Hypotension
  • Shock

Keywords

  • Fluid responsiveness
  • Ultrasound
  • Cardiac output
03

In context

Hypotension

1,021 studies on the registry are indexed under Hypotension; 172 are open to participants now.

This study's enrollment of 38 is below the median of 84 across 301 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Hospital del SAS de Jerez is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Critical ill patients with controlled mechanical ventilation and acute circulatory failure.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with controlled mechanical ventilation, equipped with an indwelling radial artery catheter and for whom the decision to give fluids will be taken because the presence of one or more clinical signs of acute circulatory failure:

    • systolic blood pressure \<90 mmHg (or a decrease >50 mmHg in previously hypertensive patients)
    • the need of vasopressor drugs
    • oliguria (urine output \<0.5 ml/kg/min for at least 2 h)
    • tachycardia
    • delayed capillary refilling
    • the presence of skin mottling

Exclusion criteria

Exclusion Criteria:

  • Contraindication for the volume administration: evidence of fluid overload and/or of hydrostatic pulmonary edema
  • Patients with instable cardiac rhythm
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
38 participants (actual)

Groups and cohorts

  • Acute circulatory failure

    Patients for whom the decision to give fluids was taken because the presence of one or more clinical signs of acute circulatory failure.

    Other: Fluid administration

Interventions

  • OtherFluid administration

    500 ml of synthetic colloid (Voluven®, hydroxyethylstarch 6%; Fresenius, Bad Homburg, Germany) infused over 30 minutes

06

What researchers measure

Primary outcomes

  1. Predictive value of respiratory variation in brachial artery peak velocity before volume expansion assessed by ROC curve. We defined responser as patients that increased stroke volume index equal or more than 15% after fluid administration.

    Time frame: immediately after volume expansion

Secondary outcomes

  1. Evaluate the predictive value of pulse pressure variation for predicting hemodynamic response to fluid administration, comparing with the predictive value of respiratory variation of brachial artery peak velocity.

    Time frame: immediately after fluid administration

  2. Evaluate the predictive value of stroke volume variation for predicting hemodynamic response to fluid administration, comparing with the predictive value of respiratory variation of brachial artery peak velocity.

    Time frame: immediately after volume expansion

07

Study locations

1 site
  • Hospital del SAS de Jerez
    Jerez de la Frontera, Cádiz 11407, Spain
08

References and documents

Publications

  • Monge Garcia MI, Gil Cano A, Diaz Monrove JC. Brachial artery peak velocity variation to predict fluid responsiveness in mechanically ventilated patients. Crit Care. 2009;13(5):R142. doi: 10.1186/cc8027. Epub 2009 Sep 3. PubMed 19728876 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00890071
Lead sponsor
Hospital del SAS de Jerez
First posted
Apr 29, 2009
Start date
Dec 2008
Primary completion
Mar 2009
Completion
Apr 2009
Last update
Apr 29, 2009

Study contacts

M. Ignacio Monge García
principal investigator · Hospital del SAS de Jerez

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion